Stereospecific Route to R-Substituted Cyclopropanes
was evaporated to dryness under reduced pressure. The reaction
mixture was poured into a saturated solution of NH4Cl, and the
product was extracted with EtOAc (3 × 10 mL). The combined
organic layers were dried over anhydrous Na2SO4 and filtered, and
the filtrate was concentrated under reduced pressure to obtain a
residue. The resulting residue was purified over a silica gel column
to afford 11 (0.18 g, 62%). Eluent: EtOAc/petroleum ether (1:3).
(CDCl3): δ 1.66-1.73 (m, 2H), 2.45 (s, 3H), 2.66 (m, 1H), 3.27
(s, 3H), 3.73 (s, 3H), 3.80 (s, 3H), 4.36 (d, J ) 3.6 Hz, 1H), 4.81
(m, 1H), 5.35 (d, J ) 1.3 Hz, 1H), 7.35 (d, J ) 8.0 Hz, 2H), 7.70
(d, J ) 8.3 Hz, 2H). 13C NMR (CDCl3): δ 21.2, 22.9 (CH2), 45.7,
48.0, 50.0, 52.1, 52.5, 55.1, 66.8, 110.9, 127.1, 129.8, 136.9, 144.4,
166.9, 168.5. IR (KBr): 1084, 1144, 1304, 1735 cm-1. Anal. calcd
for C18H22O8S: C, 54.26; H, 5.57. Found: C, 54.45; H, 5.55.
Methyl 2-O-Benzyl-3,5-cyclo-3,5-dideoxy-r-D-arabinofura-
noside (16). Compound 9 (0.38 g, 1.01 mmol) was desulfonylated
to 16 following the general procedure (0.18 g, 80%). Eluent:
EtOAc/petroleum ether (1:12). Yellow oil. [R]27D (+) 258.7 (c 2.0,
Yellow crystalline solid. Solvent of crystallization: DCM and
1
petroleum ether. [R]27 (+) 14.0 (c 0.7, CHCl3). Mp: 140 °C. H
D
NMR (CDCl3): δ 1.80 (dd, J ) 3.0, 6.7 Hz, 1H), 1.92 (t, J ) 6.4
Hz, 1H), 2.44 (s, 3H), 3.15 (s, 3H), 3.52-3.72 (m, 3H), 4.50 (m,
1H), 4.56 (s, 1H), 7.20-7.38 (m, 7H), 7.62 (d, J ) 8.3 Hz, 2H).
13C NMR (CDCl3): δ 20.1 (CH2), 21.4, 50.7, 51.3 (CH2), 54.7,
63.8, 64.4, 115.3, 127.0, 128.0, 128.2, 128.4, 129.6, 135.3, 139.2,
144.5. Anal. calcd for C20H23NO4S: C, 64.32; H, 6.21; N, 3.75.
Found: C, 64.66; H, 5.98; N, 4.03.
1
CHCl3). H NMR (CDCl3): δ 0.73 (m, 1H), 1.14 (m, 1H), 1.80
(m, 1H), 3.33 (s, 3H), 4.15-4.27 (m, 2H), 4.41 (d, J ) 11.5 Hz,
1H), 4.63 (d, J ) 11.5 Hz, 1H), 4.73 (d, J ) 0.8 Hz, 1H), 7.28-
7.37 (m, 5H). 13C NMR (CDCl3): δ 13.8 (CH2), 18.0, 54.6, 61.5,
70.3 (CH2), 84.0, 114.2, 127.5, 127.7, 128.2, 137.6. Anal. calcd
for C13H16O3: C, 70.89; H, 7.32. Found: C, 70.53; H, 7.46.
Methyl 2-N-Benzylamino-3,5-cyclo-2,3,5-trideoxy-r-D-ara-
binofuranoside (17). To a well-stirred solution of 11 (0.25 g, 0.66
mmol) in dry MeOH (10 mL) was added Mg turnings (15 mmol)
and NiBr2 (10 mol %) under Ar. The mixture was heated at 60 °C.
After 5 h, another portion of Mg turnings (15 mmol) and dry MeOH
(5 mL) were added. The mixture was stirred for an additional 5 h
at 60 °C. The reaction mixture was filtered through Celite. The
residue was washed thoroughly with MeOH. The filtrates were
pooled together, and the liquid was evaporated under reduced
pressure. The resulting residue was dissolved in EtOAc. The
solution was washed with saturated NH4Cl solution, dried over
anhydrous Na2SO4, and filtered, and the filtrate was concentrated
under reduced pressure to obtain a residue. The residue was purified
over a silica gel column to afford 17 (0.1 g, 66%). Eluent: EtOAc/
petroleum ether (1:3). Yellow oil. [R]27D (+) 201.4 (c 0.44, CHCl3).
1H NMR (CDCl3): δ 0.62 (m, 1H), 0.94 (m, 1H), 1.75 (m, 1H),
3.33 (s, 3H), 3.55 (m, 1H), 3.72 (d, J ) 12.9 Hz, 1H), 3.86 (d, J
) 12.9 Hz, 1H), 4.10 (m, 1H), 4.52 (s, 1H), 7.27-7.35 (m, 5H).
13C NMR (CDCl3): δ 13.0 (CH2), 18.9, 52.1 (CH2), 55.1, 60.1,
64.9, 115.0, 127.1, 128.2, 128.4, 139.9. Anal. calcd for C13H17-
NO2: C, 71.21; H, 7.81; N, 6.39. Found: C, 71.47; H, 8.22; N,
6.42. HRMS [ES+, (M + H)+]; for C13H18NO2: calcd 220.1338,
obsd 220.1341.
Methyl 3,5-Cyclo-2-bis(methoxycarbonylmethyl)-3-(4-meth-
ylphenyl)sulfonyl-2,3,5-trideoxy-R-D-arabinofuranoside (12). Com-
pound 6R (0.98 g, 2.7 mmol) was converted to 12 following the
general procedure (0.95 g, 88%). Eluent: EtOAc/petroleum ether
(1:3). White crystalline solid. Solvent of crystallization: EtOAc
and petroleum ether. Mp: 90 °C. [R]27 (+) 47.5 (c 1.8, CHCl3).
D
1H NMR (CDCl3): δ 1.71 (dd, J ) 2.9, 7.6 Hz, 1H), 2.11 (t, J )
6.5 Hz, 1H), 2.46 (s, 3H), 3.04 (s, 3H), 3.26 (m, 1H), 3.43 (m,
1H), 3.71 (s, 3H), 3.77 (s, 3H), 4.34 (m, 1H), 4.67 (d, J ) 1.1 Hz,
1H), 7.37 (d, J ) 8.2 Hz, 2H), 7.77 (d, J ) 8.2 Hz, 2H). 13C NMR
(CDCl3): δ 21.5, 22.2 (CH2), 46.8, 48.5, 50.5, 52.7, 52.9, 54.7,
64.5, 113.5, 129.1, 129.6, 134.4, 144.8, 166.9, 167.9. IR (KBr):
1105, 1305, 1329, 1435, 1732, 1756 cm-1. Anal. calcd for
C18H22O8S: C, 54.26; H, 5.57. Found: C, 54.58; H, 5.39.
Methyl 3,5-Cyclo-3,5-dideoxy-2-O-methyl-3-(4-methylphenyl-
)sulfonyl-â-D-arabinofuranoside (13a) and Methyl 3,5-Cyclo-
3,5-dideoxy-2-O-methyl-3-(4-methylphenyl)sulfonyl-â-D-ribo-
furanoside (13b). Compound 6â (0.42 g, 1.2 mmol) was converted
to 13a/13b (1:1) following the general procedure (0.31 g, 90%),
which was separated by column chromatography. Compound 13a:
eluent: EtOAc/petroleum ether (1:3). Yellow gum. [R]27D (-) 120.6
1
(c 1.2, CHCl3). H NMR (CDCl3): δ 1.64 (m, 1H), 2.07 (dd, J )
3.1, 6.9 Hz, 1H), 2.43 (s, 3H), 3.21 (s, 3H), 3.38 (s, 3H), 4.50 (m,
1H), 4.63 (m, 1H), 5.00 (d, J ) 5.1 Hz, 1H), 7.33 (d, J ) 7.9 Hz,
2H), 7.75 (d, J ) 8.3 Hz, 2H). 13C NMR (CDCl3): δ 19.9 (CH2),
21.5, 48.6, 56.3, 58.2, 61.9, 80.7, 105.1, 128.0, 129.6, 136.3, 144.6.
Anal. calcd for C14H18O5S: C, 56.36; H, 6.08. Found: C, 56.73;
H, 5.98. Compound 13b: eluent: EtOAc/petroleum ether (1:3).
White crystalline solid. Solvent of crystallization: DCM and
petroleum ether. Mp: 114 °C. [R]27D (-) 75.8 (c 0.46, CHCl3). 1H
NMR (CDCl3): δ 1.70 (dd, J ) 3.1, 7.2 Hz, 1H), 2.01 (t, J ) 6.8
Hz, 1H), 2.43 (s, 3H), 3.28 (s, 6H), 3.76 (s, 1H), 4.53 (m, 1H),
4.88 (s, 1H), 7.31 (d, J ) 8.3 Hz, 2H), 7.76 (d, J ) 8.3 Hz, 2H).
13C NMR (CDCl3): δ 19.2 (CH2), 21.5, 47.8, 55.1, 57.8, 63.9, 85.7,
110.1, 128.2, 129.2, 138.5, 144.0. Anal. calcd for C14H18O5S: C,
56.36; H, 6.08. Found: C, 56.40; H, 6.00.
Methyl 2-O-Benzyl-3,5-cyclo-3,5-dideoxy-â-D-ribofuranoside
(18). Compound 14 (0.32 g, 0.85 mmol) was desulfonylated to 18
following the general procedure (0.15 g, 77%). Eluent: EtOAc/
petroleum ether (1:12). Yellow oil. [R]27D (-) 30.5 (c 1.9, CHCl3).
1H NMR (CDCl3): δ 0.56 (m, 1H), 0.87 (m, 1H), 1.63 (m, 1H),
3.29 (s, 3H), 3.92 (s, 1H), 4.15 (m, 1H), 4.59 (s, 2H), 5.04 (d, J )
0.9 Hz, 1H), 7.28-7.37 (m, 5H). 13C NMR (CDCl3): δ 10.6 (CH2),
18.5, 55.0, 59.7, 71.5 (CH2), 84.7, 111.2, 127.8, 128.4, 137.8. Anal.
calcd for C13H16O3: C, 70.89; H, 7.32. Found: C, 71.0; H, 7.47.
Methyl 3,5-Cyclo-2-(methoxycarbonylmethyl)-3-(4-meth-
ylphenyl)sulfonyl-2,3,5-trideoxy-R-D-arabinofuranoside (19). Com-
pound 11 (0.6 g, 1.51 mmol) was converted to 19 following the
general procedure (0.41 g, 81%). Eluent: EtOAc/petroleum ether
(1:3). Yellow gum. [R]27 (+) 59.7 (c 3.0, CHCl3). 1H NMR
(CDCl3): δ 1.37 (dd, J )D2.8, 7.2 Hz, 1H), 1.91 (m, 1H), 2.27-
2.39 (m, 2H), 2.46 (s, 3H), 3.11 (m, 1H), 3.17 (s, 3H), 3.66 (s,
3H), 4.45 (m, 1H), 4.59 (d, J ) 2.6 Hz, 1H), 7.37 (d, J ) 8.3 Hz,
2H), 7.77 (d, J ) 8.3 Hz, 2H). 13C NMR (CDCl3): δ 20.0 (CH2),
21.6, 33.6 (CH2), 43.5, 49.3, 51.9, 55.2, 63.2, 113.9, 128.6, 129.8,
Methyl 2-O-Benzyl-3,5-cyclo-3,5-dideoxy-3-(4-methylphenyl)-
sulfonyl-â-D-ribofuranoside (14). Compound 6â (0.22 g, 0.6
mmol) was converted to 14 following the general procedure (0.19
g, 83%). Eluent: EtOAc/petroleum ether (1:5). White amorphous
solid. Mp: 172 °C. [R]27 (-) 49.5 (c 0.3, CHCl3). 1H NMR
(CDCl3): δ 1.72 (dd, J )D3.3, 7.2 Hz, 1H), 2.04 (t, J ) 6.9 Hz,
1H), 2.35 (s, 3H), 3.20 (s, 3H), 4.07 (s, 1H), 4.50-4.55 (m, 3H),
4.82 (s, 1H), 7.08 (d, J ) 7.9 Hz, 2H), 7.18-7.35 (m, 5H), 7.64
(d, J ) 8.3 Hz, 2H). 13C NMR (CDCl3): δ 19.2 (CH2), 21.4, 47.7,
55.2, 64.4, 72.9 (CH2), 84.1, 110.8, 127.8, 128.1, 128.2, 129.1,
136.5, 138.4, 143.7. Anal. calcd for C20H22O5S: C, 64.15; H, 5.92.
Found: C, 64.48; H, 5.77.
135.2, 144.9, 171.1. IR (KBr): 1139, 1166, 1303, 1316, 1736 cm-1
.
Anal. calcd for C16H20O6S: C, 56.46; H, 5.92. Found: C, 56.79;
H, 5.80.
Methyl 3,5-Cyclo-2-(methoxycarbonylmethyl)-2,3,5-trideoxy-
R-D-arabinofuranoside (20). Compound 19 (0.42 g, 1.23 mmol)
was desulfonylated to 20 following the general procedure (0.18 g,
77%). Eluent: EtOAc/petroleum ether (1:8). Yellow oil. [R]27D (+)
Methyl 3,5-Cyclo-2-bis(methoxycarbonylmethyl)-3-(4-meth-
ylphenyl)sulfonyl-2,3,5-trideoxy-â-D-ribofuranoside (15). Com-
pound 6â (0.88 g, 2.4 mmol) was converted to 15 following the
1
210.3 (c 1.4, CHCl3). H NMR (CDCl3): δ 0.44-0.58 (m, 2H),
general procedure (0.81 g, 84%). Eluent: EtOAc/petroleum ether
1.73 (m, 1H), 2.38-2.46 (m, 2H), 2.81 (m, 1H), 3.35 (s, 3H), 3.69
1
(1:3). Yellow gum. [R]27 (-) 57.3 (c 1.64, CHCl3). H NMR
(s, 3H), 4.05 (m, 1H), 4.45 (d, J ) 2.9 Hz, 1H). 13C NMR
D
J. Org. Chem, Vol. 72, No. 24, 2007 9187